{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:57:55Z","timestamp":1793195875537,"version":"4.5.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T35HL110854"],"award-info":[{"award-number":["T35HL110854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG078861\/AG078861-S1"],"award-info":[{"award-number":["AG078861\/AG078861-S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG-064003"],"award-info":[{"award-number":["AG-064003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG060621"],"award-info":[{"award-number":["AG060621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54AG054345"],"award-info":[{"award-number":["U54AG054345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Richard L Roudebush VA Medical Center","award":["I01BX005154"],"award-info":[{"award-number":["I01BX005154"]}],"id":[{"id":"https:\/\/ror.org\/01zpmbk67","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Richard L Roudebush VA Medical Center","award":["I01BX006399"],"award-info":[{"award-number":["I01BX006399"]}],"id":[{"id":"https:\/\/ror.org\/01zpmbk67","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["NIH UL1TR002529"],"award-info":[{"award-number":["NIH UL1TR002529"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This comprehensive review discusses the complex relationship between Alzheimer\u2019s disease (AD) and osteoporosis, two conditions that are prevalent in the aging population and result in adverse complications on quality of life. The purpose of this review is to succinctly elucidate the many commonalities between the two conditions, including shared pathways, inflammatory and oxidative mechanisms, and hormonal deficiencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>AD and osteoporosis share many aspects of their respective disease-defining pathophysiology. These commonalities include amyloid beta deposition, the Wnt\/\u03b2-catenin signaling pathway, and estrogen deficiency. The shared mechanisms and risk factors associated with AD and osteoporosis result in a large percentage of patients that develop both diseases. Previous literature has established that the progression of AD increases the risk of sustaining a fracture. Recent findings demonstrate that the reverse may also be true, suggesting that a fracture early in the life course can predispose one to developing AD due to the activation of these shared mechanisms. The discovery of these commonalities further guides the development of novel therapeutics in which both conditions are targeted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This detailed review delves into the commonalities between AD and osteoporosis to uncover the shared players that bring these two seemingly unrelated conditions together. The discussion throughout this review ultimately posits that the occurrence of fractures and the mechanism behind fracture healing can predispose one to developing AD later on in life, similar to how AD patients are at an increased risk of developing fractures. By focusing on the shared mechanisms between AD and osteoporosis, one can better understand the conditions individually and as a unit, thus informing therapeutic approaches and further research. This review article is part of a series of multiple manuscripts designed to determine the utility of using artificial intelligence for writing scientific reviews.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11914-023-00851-1","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T02:02:22Z","timestamp":1705543342000},"page":"483-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer\u2019s Disease and Osteoporosis"],"prefix":"10.1007","volume":"22","author":[{"given":"Hannah S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali J.","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Margetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian I.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Movila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill C.","family":"Fehrenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Kacena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"851_CR1","doi-asserted-by":"publisher","unstructured":"Kacena MA, Plotkin LI, Fehrenbacher JC. The use of artificial intelligence in writing scientific review articles. Curr Osteoporos Rep. 2024. https:\/\/doi.org\/10.1007\/s11914-023-00852-0.","DOI":"10.1007\/s11914-023-00852-0"},{"key":"851_CR2","doi-asserted-by":"publisher","unstructured":"Margetts TJ, Karnik SJ, Wang HS, et al. Use of AI language engine ChatGPT 4.0 to write a scientific review article examining the intersection of alzheimer\u2019s disease and bone. Curr Osteoporos Rep. 2024. https:\/\/doi.org\/10.1007\/s11914-023-00853-z.","DOI":"10.1007\/s11914-023-00853-z"},{"issue":"26","key":"851_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000188","volume":"93","author":"CH Tsai","year":"2014","unstructured":"Tsai CH, et al. Fracture as an independent risk factor of dementia: a nationwide population-based cohort study. Medicine (Baltimore). 2014;93(26): e188.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"851_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/2151458510389463","volume":"1","author":"SM Friedman","year":"2010","unstructured":"Friedman SM, et al. Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil. 2010;1(2):52\u201362.","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"851_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1034\/j.1601-5215.2002.51007.x","volume":"51","author":"LY Lui","year":"2003","unstructured":"Lui LY, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51(1):38\u201343.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"851_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-181249","volume":"69","author":"J Yuan","year":"2019","unstructured":"Yuan J, et al. The potential influence of bone-derived modulators on the progression of Alzheimer\u2019s disease. J Alzheimers Dis. 2019;69(1):59\u201370.","journal-title":"J Alzheimers Dis"},{"key":"851_CR7","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016.","DOI":"10.1002\/alz.13016"},{"key":"851_CR8","doi-asserted-by":"publisher","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules. 2020;25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789.","DOI":"10.3390\/molecules25245789"},{"issue":"9","key":"851_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"issue":"17","key":"851_CR10","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","volume":"88","author":"P Cras","year":"1991","unstructured":"Cras P, et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991;88(17):7552\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"851_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77(1):32\u201342.","journal-title":"Mt Sinai J Med"},{"issue":"4","key":"851_CR12","first-page":"289","volume":"47","author":"RA Armstrong","year":"2009","unstructured":"Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer\u2019s disease. Folia Neuropathol. 2009;47(4):289\u201399.","journal-title":"Folia Neuropathol"},{"issue":"10","key":"851_CR13","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/jbmr.1954","volume":"28","author":"WF Xia","year":"2013","unstructured":"Xia WF, et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res. 2013;28(10):2122\u201335.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"851_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2004.05.017","volume":"366","author":"D Paris","year":"2004","unstructured":"Paris D, et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett. 2004;366(1):80\u20135.","journal-title":"Neurosci Lett"},{"issue":"3","key":"851_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.0959-9673.2005.00428.x","volume":"86","author":"M Tabaton","year":"2005","unstructured":"Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer\u2019s disease. Int J Exp Pathol. 2005;86(3):139\u201345.","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"851_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/msj.20163","volume":"77","author":"MJ Metcalfe","year":"2010","unstructured":"Metcalfe MJ, Figueiredo-Pereira ME. Relationship between tau pathology and neuroinflammation in Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77(1):50\u20138.","journal-title":"Mt Sinai J Med"},{"key":"851_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","volume":"7","author":"X Du","year":"2018","unstructured":"Du X, Wang X, Geng M. Alzheimer\u2019s disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2.","journal-title":"Transl Neurodegener"},{"key":"851_CR18","unstructured":"\u2022 van Dyck CH, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. This study reported a reduction in cognitive and functional decline in AD patients treated with lecanemab, a new monoclonal antibody that targets amyloid beta-soluble protofibrils."},{"key":"851_CR19","first-page":"1","volume":"405","author":"N Sarafrazi","year":"2021","unstructured":"Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017\u20132018. NCHS Data Brief. 2021;405:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"1","key":"851_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46\u201356.","journal-title":"Eur J Rheumatol"},{"key":"851_CR21","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 JE LL, et al. Degradation of bone quality in a transgenic mouse model of Alzheimer\u2019s disease. J Bone Miner Res. 2022;37(12):2548\u201365. https:\/\/doi.org\/10.1002\/jbmr.4723. This primary research study utilized a 5xFAD transgenic model of AD to establish a relationship between elevated A\u03b2 levels and impairment of bone health in mice.","DOI":"10.1002\/jbmr.4723"},{"issue":"5","key":"851_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.18632\/aging.101828","volume":"11","author":"CM Dengler-Crish","year":"2019","unstructured":"Dengler-Crish CM, Elefteriou F. Shared mechanisms: osteoporosis and Alzheimer\u2019s disease? Aging (Albany NY). 2019;11(5):1317\u20138.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"851_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1047-2797(00)00085-5","volume":"10","author":"II Weller","year":"2000","unstructured":"Weller II. The relation between hip fracture and Alzheimer\u2019s disease in the canadian national population health survey health institutions data, 1994\u20131995 A cross-sectional study. Ann Epidemiol. 2000;10(7):461.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"851_CR24","first-page":"138","volume":"29","author":"YH Chen","year":"2017","unstructured":"Chen YH, Lo RY. Alzheimer\u2019s disease and osteoporosis. Ci Ji Yi Xue Za Zhi. 2017;29(3):138\u201342.","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"851_CR25","doi-asserted-by":"publisher","first-page":"1090223","DOI":"10.3389\/fnagi.2023.1090223","volume":"15","author":"H Hu","year":"2023","unstructured":"Hu H, et al. No genetic causal association between Alzheimer\u2019s disease and osteoporosis: a bidirectional two-sample Mendelian randomization study. Front Aging Neurosci. 2023;15:1090223.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"851_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pina-Crespo J, Li Y. Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"key":"851_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arr.2017.06.001","volume":"37","author":"L Garcia-Velazquez","year":"2017","unstructured":"Garcia-Velazquez L, Arias C. The emerging role of Wnt signaling dysregulation in the understanding and modification of age-associated diseases. Ageing Res Rev. 2017;37:135\u201345.","journal-title":"Ageing Res Rev"},{"issue":"22","key":"851_CR28","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1073\/pnas.0603523104","volume":"104","author":"GV De Ferrari","year":"2007","unstructured":"De Ferrari GV, et al. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2007;104(22):9434\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"851_CR29","doi-asserted-by":"publisher","first-page":"1709.e9","DOI":"10.1016\/j.neurobiolaging.2012.11.004","volume":"34","author":"MA Alarcon","year":"2013","unstructured":"Alarcon MA, et al. A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer\u2019s disease. Neurobiol Aging. 2013;34(6):1709.e9-18.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"851_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","volume":"84","author":"CC Liu","year":"2014","unstructured":"Liu CC, et al. Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease. Neuron. 2014;84(1):63\u201377.","journal-title":"Neuron"},{"issue":"12","key":"851_CR31","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/MCB.01428-09","volume":"30","author":"I Kramer","year":"2010","unstructured":"Kramer I, et al. Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30(12):3071\u201385.","journal-title":"Mol Cell Biol"},{"issue":"52","key":"851_CR32","doi-asserted-by":"publisher","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson L, et al. Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008;105(52):20764\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"851_CR33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bone.2009.03.671","volume":"44","author":"K Henriksen","year":"2009","unstructured":"Henriksen K, et al. Local communication on and within bone controls bone remodeling. Bone. 2009;44(6):1026\u201333.","journal-title":"Bone"},{"issue":"1","key":"851_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.40","volume":"19","author":"T Martin","year":"2009","unstructured":"Martin T, Gooi JH, Sims NA. Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr. 2009;19(1):73\u201388.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"851_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","volume":"6","author":"NC Inestrosa","year":"2014","unstructured":"Inestrosa NC, Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer\u2019s disease. J Mol Cell Biol. 2014;6(1):64\u201374.","journal-title":"J Mol Cell Biol"},{"key":"851_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neurobiolaging.2018.03.021","volume":"67","author":"CM Dengler-Crish","year":"2018","unstructured":"Dengler-Crish CM, et al. Evidence of Wnt\/beta-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2018;67:148\u201358.","journal-title":"Neurobiol Aging"},{"key":"851_CR37","doi-asserted-by":"publisher","unstructured":"Adair TH, Montani JP. Angiogenesis. San Rafael (CA). Integrated Systems Physiology: from Molecule to Function to Disease. 2010. https:\/\/doi.org\/10.4199\/C00017ED1V01Y201009ISP009.","DOI":"10.4199\/C00017ED1V01Y201009ISP009"},{"issue":"2","key":"851_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0925-4773(00)00532-3","volume":"100","author":"CI Colnot","year":"2001","unstructured":"Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev. 2001;100(2):245\u201350.","journal-title":"Mech Dev"},{"issue":"5","key":"851_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/jcb.10435","volume":"88","author":"LC Gerstenfeld","year":"2003","unstructured":"Gerstenfeld LC, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003;88(5):873\u201384.","journal-title":"J Cell Biochem"},{"key":"851_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.abb.2014.07.006","volume":"561","author":"U Saran","year":"2014","unstructured":"Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Arch Biochem Biophys. 2014;561:109\u201317.","journal-title":"Arch Biochem Biophys"},{"key":"851_CR41","doi-asserted-by":"publisher","first-page":"115883","DOI":"10.1016\/j.bone.2021.115883","volume":"146","author":"FUR Bhatti","year":"2021","unstructured":"Bhatti FUR, et al. The effects of high fat diet, bone healing, and BMP-2 treatment on endothelial cell growth and function. Bone. 2021;146:115883.","journal-title":"Bone"},{"issue":"1","key":"851_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s004010050386","volume":"91","author":"L Claudio","year":"1996","unstructured":"Claudio L. Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer\u2019s disease patients. Acta Neuropathol. 1996;91(1):6\u201314.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"851_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00001756-199502000-00018","volume":"6","author":"RN Kalaria","year":"1995","unstructured":"Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer\u2019s disease. NeuroReport. 1995;6(3):477\u201380.","journal-title":"NeuroReport"},{"issue":"1","key":"851_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00692225","volume":"49","author":"GL Mancardi","year":"1980","unstructured":"Mancardi GL, et al. Thickening of the basement membrane of cortical capillaries in Alzheimer\u2019s disease. Acta Neuropathol. 1980;49(1):79\u201383.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"851_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:AGEN.0000037335.17717.bf","volume":"7","author":"D Paris","year":"2004","unstructured":"Paris D, et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis. 2004;7(1):75\u201385.","journal-title":"Angiogenesis"},{"issue":"8","key":"851_CR46","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/01.STR.0000024523.82311.77","volume":"33","author":"OC Suter","year":"2002","unstructured":"Suter OC, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke. 2002;33(8):1986\u201392.","journal-title":"Stroke"},{"issue":"1","key":"851_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0169-328X(98)00190-9","volume":"62","author":"RN Kalaria","year":"1998","unstructured":"Kalaria RN, et al. Vascular endothelial growth factor in Alzheimer\u2019s disease and experimental cerebral ischemia. Brain Res Mol Brain Res. 1998;62(1):101\u20135.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"851_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","volume":"23","author":"E Tarkowski","year":"2002","unstructured":"Tarkowski E, et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer\u2019s disease and vascular dementia. Neurobiol Aging. 2002;23(2):237\u201343.","journal-title":"Neurobiol Aging"},{"issue":"Pt 4","key":"851_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1469-7580.1999.19440519.x","volume":"194","author":"A Horner","year":"1999","unstructured":"Horner A, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat. 1999;194(Pt 4):519\u201324.","journal-title":"J Anat"},{"issue":"1","key":"851_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood.V93.1.149","volume":"93","author":"K Imai","year":"1999","unstructured":"Imai K, et al. Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. Blood. 1999;93(1):149\u201356.","journal-title":"Blood"},{"issue":"4","key":"851_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1046\/j.1365-2141.1999.01644.x","volume":"106","author":"K Imai","year":"1999","unstructured":"Imai K, et al. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br J Haematol. 1999;106(4):905\u201311.","journal-title":"Br J Haematol"},{"issue":"11","key":"851_CR52","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","volume":"95","author":"A Peled","year":"2000","unstructured":"Peled A, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice. Blood. 2000;95(11):3289\u201396.","journal-title":"Blood"},{"issue":"1","key":"851_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneur.62.1.107","volume":"62","author":"ZS Tan","year":"2005","unstructured":"Tan ZS, et al. Bone mineral density and the risk of Alzheimer disease. Arch Neurol. 2005;62(1):107\u201311.","journal-title":"Arch Neurol"},{"key":"851_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12883-014-0175-2","volume":"14","author":"HK Wang","year":"2014","unstructured":"Wang HK, et al. Increased risk of hip fractures in patients with dementia: a nationwide population-based study. BMC Neurol. 2014;14:175.","journal-title":"BMC Neurol"},{"key":"851_CR55","doi-asserted-by":"publisher","first-page":"872173","DOI":"10.1100\/2012\/872173","volume":"2012","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Shen L, Ji HF. Alzheimer\u2019s disease and risk of hip fracture: a meta-analysis study. Sci World J. 2012;2012:872173.","journal-title":"Sci World J"},{"issue":"10","key":"851_CR56","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1532-5415.1999.tb05196.x","volume":"47","author":"K Yaffe","year":"1999","unstructured":"Yaffe K, et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc. 1999;47(10):1176\u201382.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"851_CR57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/1567205011666140812115818","volume":"11","author":"R Zhou","year":"2014","unstructured":"Zhou R, et al. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer\u2019s disease. Curr Alzheimer Res. 2014;11(7):706\u201313.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"851_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6874-4-2","volume":"4","author":"RA Brownbill","year":"2004","unstructured":"Brownbill RA, Ilich JZ. Cognitive function in relation with bone mass and nutrition: cross-sectional association in postmenopausal women. BMC Womens Health. 2004;4(1):2.","journal-title":"BMC Womens Health"},{"key":"851_CR59","doi-asserted-by":"crossref","unstructured":"Lary CW, et al. Bone mineral density and the risk of incident dementia: a meta-analysis. J Am Geriatr Soc. 2023.","DOI":"10.1111\/jgs.18638"},{"key":"851_CR60","doi-asserted-by":"publisher","first-page":"1105620","DOI":"10.3389\/fnagi.2023.1105620","volume":"15","author":"L Castro-Aldrete","year":"2023","unstructured":"Castro-Aldrete L, et al. Sex and gender considerations in Alzheimer\u2019s disease: the Women\u2019s Brain Project contribution. Front Aging Neurosci. 2023;15:1105620.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"851_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11910-010-0122-6","volume":"10","author":"SC Janicki","year":"2010","unstructured":"Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer\u2019s disease. Curr Neurol Neurosci Rep. 2010;10(5):359\u201366.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"851_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2265.2005.02297.x","volume":"63","author":"CE Lebrun","year":"2005","unstructured":"Lebrun CE, et al. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf). 2005;63(1):50\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"851_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0197-4580(03)00046-0","volume":"25","author":"EK Hoskin","year":"2004","unstructured":"Hoskin EK, et al. Elevated sex-hormone binding globulin in elderly women with Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(2):141\u20137.","journal-title":"Neurobiol Aging"},{"issue":"9231","key":"851_CR64","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0140-6736(00)02628-3","volume":"356","author":"K Yaffe","year":"2000","unstructured":"Yaffe K, et al. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet. 2000;356(9231):708\u201312.","journal-title":"Lancet"},{"issue":"4","key":"851_CR65","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.10677","volume":"54","author":"N Schupf","year":"2003","unstructured":"Schupf N, et al. Onset of dementia is associated with age at menopause in women with Down\u2019s syndrome. Ann Neurol. 2003;54(4):433\u20138.","journal-title":"Ann Neurol"},{"issue":"6","key":"851_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1532-5415.1999.tb01590.x","volume":"47","author":"E Barrett-Connor","year":"1999","unstructured":"Barrett-Connor E, et al. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc. 1999;47(6):685\u201391.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"851_CR67","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ana.10521","volume":"53","author":"MI Geerlings","year":"2003","unstructured":"Geerlings MI, et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol. 2003;53(5):607\u201315.","journal-title":"Ann Neurol"},{"key":"851_CR68","doi-asserted-by":"publisher","unstructured":"Cheng CH, Chen LR, Chen KH. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022;23(3):1376. https:\/\/doi.org\/10.3390\/ijms23031376.","DOI":"10.3390\/ijms23031376"},{"issue":"3","key":"851_CR69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-0029-1216281","volume":"27","author":"VW Henderson","year":"2009","unstructured":"Henderson VW. Estrogens, episodic memory, and Alzheimer\u2019s disease: a critical update. Semin Reprod Med. 2009;27(3):283\u201393.","journal-title":"Semin Reprod Med"},{"key":"851_CR70","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell R, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"851_CR71","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","volume":"24","author":"Y Abu-Amer","year":"2013","unstructured":"Abu-Amer Y. NF-kappaB signaling and bone resorption. Osteoporos Int. 2013;24(9):2377\u201386.","journal-title":"Osteoporos Int"},{"issue":"2","key":"851_CR72","first-page":"115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115\u201337.","journal-title":"Endocr Rev"},{"issue":"5","key":"851_CR73","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","volume":"13","author":"BL Riggs","year":"1998","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13(5):763\u201373.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"851_CR74","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas SC, O\u2019Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699\u2013712.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"851_CR75","first-page":"4358","volume":"81","author":"L Katznelson","year":"1996","unstructured":"Katznelson L, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81(12):4358\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"851_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","volume":"157","author":"HW Daniell","year":"1997","unstructured":"Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol. 1997;157(2):439\u201344.","journal-title":"J Urol"},{"issue":"12","key":"851_CR77","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1172\/JCI10942","volume":"106","author":"A Falahati-Nini","year":"2000","unstructured":"Falahati-Nini A, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106(12):1553\u201360.","journal-title":"J Clin Invest"},{"issue":"6947","key":"851_CR78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/424389a","volume":"424","author":"K Lee","year":"2003","unstructured":"Lee K, et al. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature. 2003;424(6947):389.","journal-title":"Nature"},{"key":"851_CR79","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Xiong J, et al. FSH blockade improves cognition in mice with Alzheimer\u2019s disease. Nature 2022;603(7901):470\u2013476. This study shows the potential of FSH blocking as a new treatment for AD, as this treatment in mice led to a reduction of AD phenotype.","DOI":"10.1038\/s41586-022-04463-0"},{"issue":"2","key":"851_CR80","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2013.02.116","volume":"434","author":"W Geng","year":"2013","unstructured":"Geng W, et al. Immunization with FSHbeta fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model. Biochem Biophys Res Commun. 2013;434(2):280\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"851_CR81","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.1718144115","volume":"115","author":"Y Ji","year":"2018","unstructured":"Ji Y, et al. Epitope-specific monoclonal antibodies to FSHbeta increase bone mass. Proc Natl Acad Sci U S A. 2018;115(9):2192\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7656","key":"851_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature22342","volume":"546","author":"P Liu","year":"2017","unstructured":"Liu P, et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017;546(7656):107\u201312.","journal-title":"Nature"},{"key":"851_CR83","doi-asserted-by":"publisher","unstructured":"\u2022 Gera S, et al. FSH-blocking therapeutic for osteoporosis. Elife. 2022;11:e78022. https:\/\/doi.org\/10.7554\/eLife.78022. This study discussed the efficacy of FSH blockade in osteoporosis treatment in mice and introduced a new FSH-blocking antibody to be used in human trials.","DOI":"10.7554\/eLife.78022"},{"issue":"4","key":"851_CR84","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"2","key":"851_CR85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"7","key":"851_CR86","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848\u201350.","journal-title":"Nat Neurosci"},{"issue":"4","key":"851_CR87","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron"},{"issue":"1","key":"851_CR88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-020-00409-0","volume":"15","author":"VS Jadhav","year":"2020","unstructured":"Jadhav VS, et al. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice. Mol Neurodegener. 2020;15(1):62.","journal-title":"Mol Neurodegener"},{"key":"851_CR89","doi-asserted-by":"publisher","unstructured":"Lee-Gosselin A, et al. TREM2-deficient microglia attenuate tau spreading in vivo. Cells. 2023;12(12):1597. https:\/\/doi.org\/10.3390\/cells12121597.","DOI":"10.3390\/cells12121597"},{"key":"851_CR90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-6-55","volume":"6","author":"M Olabarria","year":"2011","unstructured":"Olabarria M, et al. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer\u2019s disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegener. 2011;6:55.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"851_CR91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131(1):87\u2013102.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"851_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21(2):195\u2013218.","journal-title":"Brain Res Brain Res Rev"},{"issue":"2","key":"851_CR93","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.42.2.447","volume":"42","author":"PL McGeer","year":"1992","unstructured":"McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer\u2019s disease. Neurology. 1992;42(2):447\u20139.","journal-title":"Neurology"},{"issue":"6","key":"851_CR94","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","volume":"188","author":"K Otero","year":"2012","unstructured":"Otero K, et al. TREM2 and beta-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J Immunol. 2012;188(6):2612\u201321.","journal-title":"J Immunol"},{"issue":"2","key":"851_CR95","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1359\/JBMR.051016","volume":"21","author":"MB Humphrey","year":"2006","unstructured":"Humphrey MB, et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res. 2006;21(2):237\u201345.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"851_CR96","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jbmr.4572","volume":"37","author":"AL Essex","year":"2022","unstructured":"Essex AL, et al. Triggering receptor expressed on myeloid cells 2 (TREM2) R47H variant causes distinct age- and sex-dependent musculoskeletal alterations in mice. J Bone Miner Res. 2022;37(7):1366\u201381.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"851_CR97","first-page":"376","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7(5):376\u201385.","journal-title":"Neural Regen Res"},{"key":"851_CR98","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","volume":"49","author":"L Cassidy","year":"2020","unstructured":"Cassidy L, et al. Oxidative stress in Alzheimer\u2019s disease: a review on emergent natural polyphenolic therapeutics. Complement Ther Med. 2020;49:102294.","journal-title":"Complement Ther Med"},{"issue":"1","key":"851_CR99","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"A Gella","year":"2009","unstructured":"Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88\u201393.","journal-title":"Cell Adh Migr"},{"issue":"10","key":"851_CR100","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2174\/0929867053764635","volume":"12","author":"M Valko","year":"2005","unstructured":"Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161\u2013208.","journal-title":"Curr Med Chem"},{"issue":"1","key":"851_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","volume":"68","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, et al. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997;68(1):255\u201364.","journal-title":"J Neurochem"},{"issue":"7","key":"851_CR102","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00204-015-1517-6","volume":"89","author":"MA Bradley-Whitman","year":"2015","unstructured":"Bradley-Whitman MA, Lovell MA. Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol. 2015;89(7):1035\u201344.","journal-title":"Arch Toxicol"},{"issue":"1","key":"851_CR103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1471-4159.1997.69010273.x","volume":"69","author":"JN Keller","year":"1997","unstructured":"Keller JN, et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem. 1997;69(1):273\u201384.","journal-title":"J Neurochem"},{"issue":"4\u20135","key":"851_CR104","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0143-4160(03)00128-3","volume":"34","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Chan SL. Neuronal and glial calcium signaling in Alzheimer\u2019s disease. Cell Calcium. 2003;34(4\u20135):385\u201397.","journal-title":"Cell Calcium"},{"issue":"2","key":"851_CR105","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0014-4886(02)00059-6","volume":"180","author":"E Tamagno","year":"2003","unstructured":"Tamagno E, et al. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol. 2003;180(2):144\u201355.","journal-title":"Exp Neurol"},{"issue":"15","key":"851_CR106","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2106\/JBJS.20.00989","volume":"103","author":"JS Kimball","year":"2021","unstructured":"Kimball JS, Johnson JP, Carlson DA. Oxidative stress and osteoporosis. J Bone Joint Surg Am. 2021;103(15):1451\u201361.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"851_CR107","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00223-015-9961-0","volume":"96","author":"F Fontani","year":"2015","unstructured":"Fontani F, et al. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL\/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1\/2 signalling. Calcif Tissue Int. 2015;96(4):335\u201346.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"851_CR108","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jbspin.2012.03.007","volume":"79","author":"E Filaire","year":"2012","unstructured":"Filaire E, Toumi H. Reactive oxygen species and exercise on bone metabolism: friend or enemy? Joint Bone Spine. 2012;79(4):341\u20136.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"851_CR109","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/febs.12075","volume":"280","author":"C Romagnoli","year":"2013","unstructured":"Romagnoli C, et al. Role of GSH\/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. FEBS J. 2013;280(3):867\u201379.","journal-title":"FEBS J"},{"issue":"1","key":"851_CR110","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","volume":"314","author":"XC Bai","year":"2004","unstructured":"Bai XC, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 2004;314(1):197\u2013207.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"851_CR111","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00223-013-9774-y","volume":"94","author":"T Bellido","year":"2014","unstructured":"Bellido T. Osteocyte-driven bone remodeling. Calcif Tissue Int. 2014;94(1):25\u201334.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"851_CR112","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26(2):229\u201338.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"851_CR113","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bone.2012.11.038","volume":"54","author":"RL Jilka","year":"2013","unstructured":"Jilka RL, Noble B, Weinstein RS. Osteocyte apoptosis. Bone. 2013;54(2):264\u201371.","journal-title":"Bone"},{"issue":"9","key":"851_CR114","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/jcb.23164","volume":"112","author":"SA Al-Dujaili","year":"2011","unstructured":"Al-Dujaili SA, et al. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. J Cell Biochem. 2011;112(9):2412\u201323.","journal-title":"J Cell Biochem"},{"issue":"2","key":"851_CR115","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bone.2010.09.014","volume":"48","author":"LE Mulcahy","year":"2011","unstructured":"Mulcahy LE, et al. RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone. 2011;48(2):182\u20138.","journal-title":"Bone"},{"key":"851_CR116","unstructured":"Singh R, Sadiq NM. Cholinesterase inhibitors. In: StatPearls. Treasure Island (FL); 2023.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544336\/. Accessed 19 Sept 2023."},{"key":"851_CR117","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.trci.2019.03.004","volume":"5","author":"J Eldufani","year":"2019","unstructured":"Eldufani J, Blaise G. The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: a review of recent clinical applications. Alzheimers Dement (N Y). 2019;5:175\u201383.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"851_CR118","first-page":"1479","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review). Mol Med Rep. 2019;20(2):1479\u201387.","journal-title":"Mol Med Rep"},{"issue":"4","key":"851_CR119","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1041\u20138.","journal-title":"J Alzheimers Dis"},{"key":"851_CR120","unstructured":"Kuns B, Rosani A, Varghese D. Memantine. In: StatPearls. Treasure Island (FL); 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500025\/. Accessed 19 Sept 2023."},{"key":"851_CR121","doi-asserted-by":"publisher","unstructured":"Passeri E, et al. Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci. 2022;23(22):13954. https:\/\/doi.org\/10.3390\/ijms232213954.","DOI":"10.3390\/ijms232213954"},{"issue":"1","key":"851_CR122","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou M, et al. Alzheimer\u2019s disease prevention: from risk factors to early intervention. Alzheimers Res Ther. 2017;9(1):71.","journal-title":"Alzheimers Res Ther"},{"key":"851_CR123","first-page":"9343514","volume":"2022","author":"SA Beshir","year":"2022","unstructured":"Beshir SA, et al. Aducanumab therapy to treat Alzheimer\u2019s disease: a narrative review. Int J Alzheimers Dis. 2022;2022:9343514.","journal-title":"Int J Alzheimers Dis"},{"key":"851_CR124","doi-asserted-by":"publisher","unstructured":"Tonk CH, et al. Therapeutic treatments for osteoporosis-which combination of pills is the best among the bad? Int J Mol Sci. 2022;23(3):1393. https:\/\/doi.org\/10.3390\/ijms23031393.","DOI":"10.3390\/ijms23031393"},{"key":"851_CR125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000445173","volume":"47","author":"AR Nicholls","year":"2016","unstructured":"Nicholls AR, Holt RI. Growth hormone and insulin-like growth factor-1. Front Horm Res. 2016;47:101\u201314.","journal-title":"Front Horm Res"},{"key":"851_CR126","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00003086-198310000-00016","volume":"179","author":"MC de Vernejoul","year":"1983","unstructured":"de Vernejoul MC, et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res. 1983;179:107\u201315.","journal-title":"Clin Orthop Relat Res"},{"key":"851_CR127","doi-asserted-by":"publisher","unstructured":"Russow G, et al. Anabolic therapies in osteoporosis and bone regeneration. Int J Mol Sci. 2018;20(1):83. https:\/\/doi.org\/10.3390\/ijms20010083.","DOI":"10.3390\/ijms20010083"},{"key":"851_CR128","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi H, et al. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review. Front Med (Lausanne). 2017;4:234.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"851_CR129","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","volume":"103","author":"A Makino","year":"2018","unstructured":"Makino A, et al. Abaloparatide exerts bone anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide. Calcif Tissue Int. 2018;103(3):289\u201397.","journal-title":"Calcif Tissue Int"},{"key":"851_CR130","doi-asserted-by":"publisher","unstructured":"\u2022 Zhang M, Hu S, Sun X. Alzheimer\u2019s disease and impaired bone microarchitecture, regeneration and potential genetic links. Life (Basel). 2023;13(2):373. https:\/\/doi.org\/10.3390\/life13020373. This is a comprehensive review article that explores mechanisms and genetic influences shared between AD and osteoporosis.","DOI":"10.3390\/life13020373"},{"issue":"6","key":"851_CR131","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1532-5415.1994.tb06859.x","volume":"42","author":"LJ Melton 3rd","year":"1994","unstructured":"Melton LJ 3rd, et al. Fracture risk in patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 1994;42(6):614\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"851_CR132","doi-asserted-by":"publisher","first-page":"e59124","DOI":"10.1371\/journal.pone.0059124","volume":"8","author":"AM Tolppanen","year":"2013","unstructured":"Tolppanen AM, et al. Incident hip fractures among community dwelling persons with Alzheimer\u2019s disease in a Finnish nationwide register-based cohort. PLoS ONE. 2013;8(3):e59124.","journal-title":"PLoS ONE"},{"issue":"11","key":"851_CR133","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/mds.25674","volume":"28","author":"M Amboni","year":"2013","unstructured":"Amboni M, Barone P, Hausdorff JM. Cognitive contributions to gait and falls: evidence and implications. Mov Disord. 2013;28(11):1520\u201333.","journal-title":"Mov Disord"},{"issue":"2","key":"851_CR134","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2004.03.033","volume":"223","author":"Y Sato","year":"2004","unstructured":"Sato Y, et al. Risk factors for hip fracture among elderly patients with Alzheimer\u2019s disease. J Neurol Sci. 2004;223(2):107\u201312.","journal-title":"J Neurol Sci"},{"issue":"10","key":"851_CR135","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1532-5415.1995.tb07005.x","volume":"43","author":"E Kipen","year":"1995","unstructured":"Kipen E, et al. Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995;43(10):1088\u201391.","journal-title":"J Am Geriatr Soc"},{"issue":"19","key":"851_CR136","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1001\/jama.284.19.2448-JLT1115-4-1","volume":"284","author":"RS Morrison","year":"2000","unstructured":"Morrison RS, Siu AL. Mortality from pneumonia and hip fractures in patients with advanced dementia. JAMA. 2000;284(19):2447\u20138.","journal-title":"JAMA"},{"issue":"6","key":"851_CR137","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/ageing\/29.6.537","volume":"29","author":"JD Holmes","year":"2000","unstructured":"Holmes JD, House AO. Psychiatric illness in hip fracture. Age Ageing. 2000;29(6):537\u201346.","journal-title":"Age Ageing"},{"issue":"9","key":"851_CR138","first-page":"691","volume":"29","author":"M Matsueda","year":"2000","unstructured":"Matsueda M, Ishii Y. The relationship between dementia score and ambulatory level after hip fracture in the elderly. Am J Orthop (Belle Mead NJ). 2000;29(9):691\u20133.","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"6","key":"851_CR139","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.bone.2010.08.019","volume":"47","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, et al. The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women\u2013a joint analysis of the Nagano, Miyama, and Taiji Cohorts. Bone. 2010;47(6):1064\u201370.","journal-title":"Bone"},{"issue":"1","key":"851_CR140","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ageing\/afq146","volume":"40","author":"NL Baker","year":"2011","unstructured":"Baker NL, et al. Hip fracture risk and subsequent mortality among Alzheimer\u2019s disease patients in the United Kingdom, 1988\u20132007. Age Ageing. 2011;40(1):49\u201354.","journal-title":"Age Ageing"},{"issue":"8","key":"851_CR141","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s11999-011-1779-0","volume":"469","author":"SV Bukata","year":"2011","unstructured":"Bukata SV, Kates SL, O\u2019Keefe RJ. Short-term and long-term orthopaedic issues in patients with fragility fractures. Clin Orthop Relat Res. 2011;469(8):2225\u201336.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"851_CR142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/2151458512454878","volume":"3","author":"LJ Gleason","year":"2012","unstructured":"Gleason LJ, et al. Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil. 2012;3(2):79\u201383.","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"10","key":"851_CR143","doi-asserted-by":"publisher","first-page":"e19048","DOI":"10.1097\/MD.0000000000019048","volume":"99","author":"SY Kim","year":"2020","unstructured":"Kim SY, et al. Increased risk of dementia after distal radius, hip, and spine fractures. Medicine (Baltimore). 2020;99(10):e19048.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"851_CR144","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/00016489.2017.1408142","volume":"138","author":"S Goto","year":"2018","unstructured":"Goto S, et al. Relationship between cognitive function and balance in a community-dwelling population in Japan. Acta Otolaryngol. 2018;138(5):471\u20134.","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"851_CR145","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.gaitpost.2013.07.001","volume":"39","author":"T Deschamps","year":"2014","unstructured":"Deschamps T, et al. Postural control and cognitive decline in older adults: position versus velocity implicit motor strategy. Gait Posture. 2014;39(1):628\u201330.","journal-title":"Gait Posture"},{"issue":"1","key":"851_CR146","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000445831","volume":"63","author":"L Bahureksa","year":"2017","unstructured":"Bahureksa L, et al. The impact of mild cognitive impairment on gait and balance: a systematic review and meta-analysis of studies using instrumented assessment. Gerontology. 2017;63(1):67\u201383.","journal-title":"Gerontology"},{"issue":"2","key":"851_CR147","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/003655000750045550","volume":"32","author":"EK Kristinsdottir","year":"2000","unstructured":"Kristinsdottir EK, Jarnlo GB, Magnusson M. Asymmetric vestibular function in the elderly might be a significant contributor to hip fractures. Scand J Rehabil Med. 2000;32(2):56\u201360.","journal-title":"Scand J Rehabil Med"},{"issue":"4","key":"851_CR148","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/000164801300366624","volume":"121","author":"EK Kristinsdottir","year":"2001","unstructured":"Kristinsdottir EK, et al. Observation of vestibular asymmetry in a majority of patients over 50 years with fall-related wrist fractures. Acta Otolaryngol. 2001;121(4):481\u20135.","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"851_CR149","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000366556","volume":"61","author":"E Ekvall Hansson","year":"2015","unstructured":"Ekvall Hansson E, Dahlberg LE, Magnusson M. Vestibular rehabilitation affects vestibular asymmetry among patients with fall-related wrist fractures - a randomized controlled trial. Gerontology. 2015;61(4):310\u20138.","journal-title":"Gerontology"},{"issue":"5","key":"851_CR150","first-page":"1233","volume":"22","author":"MD Yu","year":"2018","unstructured":"Yu MD, Su BH, Zhang XX. Morphologic and molecular alteration during tibia fracture healing in rat. Eur Rev Med Pharmacol Sci. 2018;22(5):1233\u201340.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"851_CR151","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12974-016-0636-1","volume":"13","author":"RJ Hall","year":"2016","unstructured":"Hall RJ, et al. Cerebrospinal fluid levels of neopterin are elevated in delirium after hip fracture. J Neuroinflammation. 2016;13(1):170.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"851_CR152","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/jgs.14238","volume":"64","author":"BE Neerland","year":"2016","unstructured":"Neerland BE, et al. Associations between delirium and preoperative cerebrospinal fluid C-reactive protein, interleukin-6, and interleukin-6 receptor in individuals with acute hip fracture. J Am Geriatr Soc. 2016;64(7):1456\u201363.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"851_CR153","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, et al. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: a meta-analysis. Alzheimers Dement. 2018;14(11):1450\u20139.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"851_CR154","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cbf.1199","volume":"23","author":"H Yeler","year":"2005","unstructured":"Yeler H, Tahtabas F, Candan F. Investigation of oxidative stress during fracture healing in the rats. Cell Biochem Funct. 2005;23(2):137\u20139.","journal-title":"Cell Biochem Funct"},{"issue":"3","key":"851_CR155","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3233\/JAD-170732","volume":"62","author":"P Mecocci","year":"2018","unstructured":"Mecocci P, et al. A long journey into aging, brain aging, and Alzheimer\u2019s disease following the oxidative stress tracks. J Alzheimers Dis. 2018;62(3):1319\u201335.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"851_CR156","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000334565","volume":"58","author":"M Piirtola","year":"2012","unstructured":"Piirtola M, et al. Fractures as an independent predictor of functional decline in older people: a population-based study with an 8-year follow-up. Gerontology. 2012;58(4):296\u2013304.","journal-title":"Gerontology"},{"issue":"4","key":"851_CR157","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/gps.4832","volume":"33","author":"B Olofsson","year":"2018","unstructured":"Olofsson B, et al. Development of dementia in patients with femoral neck fracture who experience postoperative delirium-a three-year follow-up study. Int J Geriatr Psychiatry. 2018;33(4):623\u201332.","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-023-00851-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:09:01Z","timestamp":1727190541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-023-00851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":157,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s11914-023-00851-1","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"21 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kacena is Editor-in-Chief for Current Osteoporosis Reports. Drs. Fehrenbacher and Plotkin are Section Editors for Current Osteoporosis Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}